← Association for Accessible Medicines
FDANonrulemakingFDA-2023-D-1955

E6(R3) Guideline for Good Clinical Practice; International Council for Harmonisation; Draft Guidance for Industry; Availability

RIN
—
Last modified
Sep 10, 2025
Comment window
closed 1057d ago
Association for Accessible Medicines filings
1

Activity

Association for Accessible Medicines filed 1 comment on this docket between Sep 5, 2023 and Sep 5, 2023. 0 other organizations filed here. The comment window closed 1057d ago.

What Association for Accessible Medicines filed (1)

Sep 5, 2023· Comment from Association for Accessible Medicines (AAM)· FDA-2023-D-1955-0021

FDA, Please find attached comments from The Association for Accessible Medicines (AAM) regarding Docket No. FDA-2023-D-1955: "E6(R3) Guideline for Good Clinical Practice; International Council for Harmonisation; Draft Guidance for Industry" Thanks, Scott Kuzner, Ph.D., Senior Director, Sciences and Regulatory Affairs Association for AAM

View on regulations.gov →

Abstract

Open

View on regulations.gov →

Co-filers (0)

See everyone who commented →
E6(R3) Guideline for Good Clinical Practice; International Council for Harmonisation; Draft Guidance for Industry; Availability (FDA) — Association for Accessible Medicines | OpenPolis